Braulio Peramo

ORCID: 0000-0002-9761-6295 · 4 papers in corpus
observational 2026
Prevalence of chromosomal abnormalities and polymorphisms in 4,672 infertile patients undergoing assisted reproductive techniques in the United Arab Emirates population
Frontiers in reproductive health ·doi:10.3389/frph.2026.1750389

INTRODUCTION: Chromosomal abnormalities (CA) are a key genetic contributor to infertility, particularly in regions with high consanguinity. Despite growing utilization of assisted reproductive techniques (ART) in the Gulf region, large-scal…

review 2026
Redox imbalance in infertility and assisted reproduction: biomarkers, mechanisms, multi-omics integration, and personalised therapeutic strategies
Frontiers in medicine ·doi:10.3389/fmed.2026.1870154

Redox biology occupies a central but paradoxical role in human reproduction. Reactive oxygen species (ROS) are indispensable mediators of sperm capacitation, oocyte activation, embryo development, and trophoblast invasion, yet excessive ROS…

guideline 2024
FSH/LH co-stimulation in Advanced Maternal Age (AMA) and hypo-responder patients - Arabian gulf delphi consensus group
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1506332

BACKGROUND: In a global effort to assess expert perspectives on the use of recombinant gonadotropins, recombinant human luteinizing hormone (r-hLH) and recombinant human follicle-stimulating hormone (r-hFSH), a consensus meeting was held in…

guideline 2023
ESHRE guideline: recurrent pregnancy loss: an update in 2022
Human reproduction open ·doi:10.1093/hropen/hoad002

STUDY QUESTION: What are the updates for the recommended management of women with recurrent pregnancy loss (RPL) based on the best available evidence in the literature from 2017 to 2022? SUMMARY ANSWER: The guideline development group (GDG…